Effects of terbogrel on platelet function and prostaglandin endoperoxide transfer

This publication has 13 references indexed in Scilit:

• Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and Prophylaxis
  Seminars in Thrombosis and Hemostasis, 1997
• Thromboxane A2 induces cell signaling but requires platelet-derived growth factor to act as a mitogen
  European Journal of Pharmacology, 1997
• Therapeutic Aspects of Platelet Pharmacology
  Published by Springer Nature ,1997
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Aspirin-induced decline in prostacyclin production in patients with coronary artery disease is due to decreased endoperoxide shift. Analysis of the effects of a combination of aspirin and n-3 fatty acids on the eicosanoid profile.
  Circulation, 1991
• Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back
  Trends in Pharmacological Sciences, 1989
• Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
• Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
  New England Journal of Medicine, 1984
• Synthesis of Prostacyclin from Platelet-derived Endoperoxides by Cultured Human Endothelial Cells
  Journal of Clinical Investigation, 1980
• Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
  Prostaglandins, 1976